/ Solutions / Drug Research and Development Solutions / Pharmacovigilance
Use of AI technology on scale may enable the pharmacovigilance industry to increase operational
efficiency and the consistency of data quality when processing individual case safety reports□ICSRs□.
MedAI’s AI platform is mainly focusing on the PV signal management of artificial intelligence algorithm
and deep mining of PV database. It includes clinical stage and post marketing pharmacovigilance services,
and provides risk signal early warning modules.
Establish an international knowledge map and develop an in-depth learning platform.
Enhance and increase the efficiency of drug safety professionals' work.
Focus on monitoring, safety re-evaluation and automatic revision of instructions.
Provide post market safety monitoring and re-evaluation services for drugs.
Increasing Amount of
Efficient Drug System
Establishing a solid pharmacovigilance system is the cornerstone of new drugs research and
development. The innovative AI technologies applied in pharmacovigilance provide an opportunity to
further increase the efficiency of case handling, while maintaining consistent high quality and compliance
standards. By using AI to accelerate the monitoring of patient safety data, MedAI’s experts hope to find
any potential drug-related side effects earlier, give early warning in time, and effectively avoid potential
safety risks in advance, by continuously train and track the signal.
Deep Neural Network
The innovative ability to apply advanced AI and machine learning technologies to pharmacovigilance
provides an opportunity for us to further increase the efficiency of pharmacovigilance operation mode
and case handling, while maintaining consistent high quality and compliance standards. Applying